Literature DB >> 23296393

Bone research in 2012: the ups and downs of bone in health and rheumatic disease.

Ulrike Harre1, Georg Schett.   

Abstract

In 2012, several new concepts emerged that widen our view of the regulation of bone mass in health and disease. Three key studies outline these discoveries, which affect our understanding of the skeletal system, particularly its physiological function and the changes it undergoes during inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296393     DOI: 10.1038/nrrheum.2012.219

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  9 in total

Review 1.  Cellular communications in bone homeostasis and repair.

Authors:  Ken-Ichi Nakahama
Journal:  Cell Mol Life Sci       Date:  2010-08-08       Impact factor: 9.261

2.  Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.

Authors:  Ulrike Harre; Dan Georgess; Holger Bang; Aline Bozec; Roland Axmann; Elena Ossipova; Per-Johan Jakobsson; Wolfgang Baum; Falk Nimmerjahn; Eszter Szarka; Gabriella Sarmay; Grit Krumbholz; Elena Neumann; Rene Toes; Hans-Ulrich Scherer; Anca Irinel Catrina; Lars Klareskog; Pierre Jurdic; Georg Schett
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

3.  Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA).

Authors:  Yukihiko Saeki; Eriko Kudo-Tanaka; Shiro Ohshima; Masato Matsushita; So-ichiro Tsuji; Yu-ichi Maeda; Maiko Yoshimura; Akane Watanabe; Yoshinori Katada; Yoshinori Harada; Kenji Ichikawa; Yasuo Suenaga; Yusuke Ohta; Shigeto Tohma
Journal:  Rheumatol Int       Date:  2012-03-29       Impact factor: 2.631

4.  Osteoprotection by semaphorin 3A.

Authors:  Mikihito Hayashi; Tomoki Nakashima; Masahiko Taniguchi; Tatsuhiko Kodama; Atsushi Kumanogoh; Hiroshi Takayanagi
Journal:  Nature       Date:  2012-05-03       Impact factor: 49.962

Review 5.  Developments in therapies for spondyloarthritis.

Authors:  Joachim Sieper
Journal:  Nat Rev Rheumatol       Date:  2012-04-10       Impact factor: 20.543

6.  Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones.

Authors:  Y Luo; D Raible; J A Raper
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

7.  IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.

Authors:  Jonathan P Sherlock; Barbara Joyce-Shaikh; Scott P Turner; Cheng-Chi Chao; Manjiri Sathe; Jeff Grein; Daniel M Gorman; Edward P Bowman; Terrill K McClanahan; Jennifer H Yearley; Gérard Eberl; Christopher D Buckley; Robert A Kastelein; Robert H Pierce; Drake M Laface; Daniel J Cua
Journal:  Nat Med       Date:  2012-07-01       Impact factor: 53.440

Review 8.  Bone cells and the mechanisms of bone remodelling.

Authors:  Andrea Del Fattore; Anna Teti; Nadia Rucci
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

Review 9.  Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis.

Authors:  Tobias Braun; Jochen Zwerina
Journal:  Arthritis Res Ther       Date:  2011-07-28       Impact factor: 5.156

  9 in total
  4 in total

Review 1.  Podosome organization drives osteoclast-mediated bone resorption.

Authors:  Dan Georgess; Irma Machuca-Gayet; Anne Blangy; Pierre Jurdic
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

2.  Effect of r-Mt-Cpn10 on human osteoblast cells.

Authors:  Yuanyu Zhang; Xia Liu; Kun Li; Jingping Bai
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 3.  Semaphorins and their Signaling Mechanisms.

Authors:  Laura Taylor Alto; Jonathan R Terman
Journal:  Methods Mol Biol       Date:  2017

4.  Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling.

Authors:  María P Menéndez-Gutiérrez; Tamás Rőszer; Lucía Fuentes; Vanessa Núñez; Amelia Escolano; Juan Miguel Redondo; Nora De Clerck; Daniel Metzger; Annabel F Valledor; Mercedes Ricote
Journal:  J Clin Invest       Date:  2015-01-09       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.